Holen Sie sich die Stockscreener-App
13.78
1.18%
0.19
Schlusskurs vom Vortag:
$13.59
Offen:
$13.39
24-Stunden-Volumen:
669.26K
Relative Volume:
0.42
Marktkapitalisierung:
$1.23B
Einnahmen:
$-249.00K
Nettoeinkommen (Verlust:
$-187.60M
KGV:
-5.512
EPS:
-2.5
Netto-Cashflow:
$-201.88M
1W Leistung:
-0.94%
1M Leistung:
+46.59%
6M Leistung:
+311.68%
1J Leistung:
+349.35%
1-Tages-Spanne:
$13.27
$13.96
1-Wochen-Bereich:
$13.27
$15.14
52-Wochen-Spanne:
$2.865
$15.14
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
Firmenname
Amylyx Pharmaceuticals Inc
Sektor
Branche
Telefon
617-683-0917
Adresse
43 THORNDIKE STREET, CAMBRIDGE
Vergleichen Sie AMLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
13.75 | 1.45B | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.97 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.28 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.79 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
776.00 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-06-24 | Eingeleitet | Guggenheim | Buy |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-05-30 | Eingeleitet | TD Cowen | Buy |
| 2025-04-07 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-11-18 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-03-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2024-03-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-03-08 | Herabstufung | Goldman | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-07-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-01-05 | Eingeleitet | BofA Securities | Buy |
| 2022-05-25 | Eingeleitet | Citigroup | Buy |
| 2022-04-01 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten
Will Amylyx Pharmaceuticals Inc. stock continue upward momentumJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com
Visual analytics tools that track Amylyx Pharmaceuticals Inc. performancePortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com
H.C. Wainwright, Leerink Partners, and TD Cowen Reaffirm ‘Buy’ Ratings on Amylyx Pharmaceuticals, Inc. (AMLX) - MSN
How supply chain issues affect Amylyx Pharmaceuticals Inc. stockWeekly Risk Report & Consistent Profit Alerts - newser.com
Amylyx Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 52-Week HighWhat's Next? - MarketBeat
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives $14.50 Average PT from Brokerages - MarketBeat
Amylyx Pharmaceuticals Hits New 52-Week High of $13.09 - Markets Mojo
Amylyx stock dips after pricing $60M stock offering - MSN
Amylyx Pharmaceuticals Hits New 52-Week High of $13.33 - Markets Mojo
The Goldman Sachs Group Forecasts Strong Price Appreciation for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat
Guggenheim Issues Positive Forecast for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price - MarketBeat
Advanced analytics toolkit walkthrough for Amylyx Pharmaceuticals Inc.Market Movers & AI Enhanced Execution Alerts - newser.com
Market Fear: Is Amylyx Pharmaceuticals Inc. a turnaround storyJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - خودرو بانک
Goldman Sachs Group Inc. Boosts Stake in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Layoff Watch: Whats the fair value of Amylyx Pharmaceuticals Inc stockJuly 2025 Sector Moves & Low Risk High Reward Ideas - khodrobank.com
Woodline Partners LP Takes Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
WilmerHale Advises Underwriters in Public Offering of Amylyx Pharmaceuticals - WilmerHale
Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 12-Month High Following Analyst Upgrade - Defense World
Market Pulse: Is Amylyx Pharmaceuticals Inc stock a good pick for beginnersSell Signal & Weekly High Conviction Ideas - خودرو بانک
Cubist Systematic Strategies LLC Cuts Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $25.00 at Guggenheim - Defense World
Dow Update: Will Aether Holdings Inc benefit from green energy policiesWeekly Profit Recap & AI Enhanced Trading Signals - khodrobank.com
Aug Reactions: Is Amylyx Pharmaceuticals Inc. showing insider buyingPortfolio Return Summary & Real-Time Volume Analysis - خودرو بانک
IPO Launch: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Volatility Report & Low Risk Investment Opportunities - خودرو بانک
Amylyx announces proposed public offering of common stock - MSN
Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap UpWhat's Next? - MarketBeat
Market Outlook: Does Amylyx Pharmaceuticals Inc. have strong EBITDA marginsJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - khodrobank.com
Movement Recap: What is Amylyx Pharmaceuticals Incs debt to equity ratioTrade Entry Summary & Growth Oriented Trade Recommendations - خودرو بانک
Is Amylyx Pharmaceuticals Inc stock a good pick for beginnersIndex Update & Precise Swing Trade Alerts - خودرو بانک
Guggenheim raises Amylyx Pharmaceuticals stock price target on PBH potential - Investing.com
Amylyx Pharmaceuticals (NASDAQ:AMLX) Hits New 1-Year HighHere's Why - MarketBeat
Will Amylyx Pharmaceuticals’ (AMLX) $175 Million Capital Raise Reshape Its Pipeline Ambitions? - Yahoo Finance
Invesco Ltd. Buys Shares of 45,694 Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals prices $175M public offering - MSN
Alyeska Investment Group L.P. Decreases Holdings in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
American Century Companies Inc. Increases Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):